Literature DB >> 16131772

Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus.

S Bhadada1, Anil Bhansali, K S S Reddy, Rekha V Bhat, N Khandelwal, A K Gupta.   

Abstract

AIM: To describe the presentation and outcome of rhino-orbital-cerebral mucormycosis (ROCM) in adolescents with type 1 diabetes mellitus (T1DM).
METHODS: The medical records of six patients of T1DM with ROCM admitted between October 2001 to January 2004 were analysed.
RESULTS: The mean (+/- SD) age and duration of DM of these patients were 16.1+/-3.0 years and 26.3 +/- 24.9 months respectively. Four patients had ROCM at presentation, while two developed it during their hospital stay when recovering from diabetic ketoacidosis. Proptosis (100%) and ptosis (100%) were the most common symptoms, and ophthalmoplegia (85%) and vision loss (85%) were the most common signs. Maxillary sinus (85%) was the commonest paranasal sinus to be involved. All patients received amphotericin B and had appropriate surgery except one. Four patients survived. Patients who had altered sensorium, facial necrosis, palatal perforation and cerebral involvement at presentation had poor outcome.
CONCLUSION: High index of suspicion of ROCM in T1DM and combined approach with amphotericin B and appropriate surgery is rewarding.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131772     DOI: 10.1007/BF02724075

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Rhinocerebral phycomycosis in association with diabetic ketoacidosis. Report of two cases and a review of clinical and experimental experience with amphotericin B therapy.

Authors:  E Abramson; D Wilson; R A Arky
Journal:  Ann Intern Med       Date:  1967-04       Impact factor: 25.391

2.  Mucormycosis in children: review of the literature and report of cases.

Authors:  M W Kline
Journal:  Pediatr Infect Dis       Date:  1985 Nov-Dec

3.  Diagnosis and management of rhino-orbitocerebral mucormycosis (phycomycosis). A report of 16 personally observed cases.

Authors:  A P Ferry; S Abedi
Journal:  Ophthalmology       Date:  1983-09       Impact factor: 12.079

Review 4.  Survival factors in rhino-orbital-cerebral mucormycosis.

Authors:  R A Yohai; J D Bullock; A A Aziz; R J Markert
Journal:  Surv Ophthalmol       Date:  1994 Jul-Aug       Impact factor: 6.048

5.  Mucormycosis caused by Rhizopus microsporus var. microsporus: cellulitis in the leg of a diabetic patient cured by amputation.

Authors:  B C West; A D Oberle; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

6.  A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability.

Authors:  W M Artis; J A Fountain; H K Delcher; H E Jones
Journal:  Diabetes       Date:  1982-12       Impact factor: 9.461

7.  The changing spectrum of disease, etiology, and diagnosis of mucormycosis.

Authors:  A M Marchevsky; E J Bottone; S A Geller; D K Giger
Journal:  Hum Pathol       Date:  1980-09       Impact factor: 3.466

8.  Survival in cerebro-rhino-orbital zygomycosis and cavernous sinus thrombosis with combined therapy.

Authors:  J L Smith; D A Stevens
Journal:  South Med J       Date:  1986-04       Impact factor: 0.954

9.  Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases.

Authors:  N A Parfrey
Journal:  Medicine (Baltimore)       Date:  1986-03       Impact factor: 1.889

10.  Clinical predictors of mucormycosis in children with type 1 diabetes mellitus.

Authors:  Julie Moye; Arlan L Rosenbloom; Janet Silverstein
Journal:  J Pediatr Endocrinol Metab       Date:  2002 Jul-Aug       Impact factor: 1.634

  10 in total
  7 in total

1.  Acute invasive fungal rhinosinusitis: our experience with 18 cases.

Authors:  Mehdi Bakhshaee; Amin Bojdi; Abolghasem Allahyari; Mohammad Reza Majidi; Sherwin Tavakol; Mohammad Javad Najafzadeh; Masoud Asghari
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-07       Impact factor: 2.503

Review 2.  Stroke in central nervous system infections.

Authors:  Francisco Javier Carod-Artal
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.714

3.  Rhino-Orbital-Cerebral Mucormycosis: Battle with the Deadly Enemy.

Authors:  Saroj Gupta; Rashmi Goyal; Navinchandra M Kaore
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2019-12-05

4.  [Mucormycosis in paranasal sinuses].

Authors:  S Volkenstein; C Unkel; A Neumann; H Sudhoff; H Dermoumi; K Jahnke; S Dazert
Journal:  HNO       Date:  2009-08       Impact factor: 1.284

5.  Basilar artery territory stroke secondary to invasive fungal sphenoid sinusitis: a case report and review of the literature.

Authors:  Katherine A Fu; Peggy L Nguyen; Nerses Sanossian
Journal:  Case Rep Neurol       Date:  2015-03-07

6.  Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.

Authors:  A Abdollahi; T Shokohi; N Amirrajab; R Poormosa; A M Kasiri; S J Motahari; S M Ghoreyshi; S A Madani; M Nikkhah; M Ghasemi; L Vahedi Larijani; M Didehdar; Z Seifi; N Gholinejad; M Ilkit
Journal:  Curr Med Mycol       Date:  2016-12

7.  Diabetes and rhino-orbito-cerebral mucormycosis - A deadly duo.

Authors:  Parminder Singh; Saurabh Arora; Naveen Mittal; Amroz Singh; Rohit Verma; Sarit Sharma; Neeraj Kumar Agrawal; Saloni Goyal
Journal:  J Diabetes Metab Disord       Date:  2021-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.